Stig Palm

2.4k total citations · 1 hit paper
53 papers, 1.9k citations indexed

About

Stig Palm is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Stig Palm has authored 53 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Radiology, Nuclear Medicine and Imaging, 20 papers in Pulmonary and Respiratory Medicine and 15 papers in Oncology. Recurrent topics in Stig Palm's work include Radiopharmaceutical Chemistry and Applications (40 papers), Medical Imaging Techniques and Applications (19 papers) and Monoclonal and Polyclonal Antibodies Research (16 papers). Stig Palm is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (40 papers), Medical Imaging Techniques and Applications (19 papers) and Monoclonal and Polyclonal Antibodies Research (16 papers). Stig Palm collaborates with scholars based in Sweden, Denmark and United States. Stig Palm's co-authors include Sture Lindegren, Tom Bäck, Holger Jensen, Lars Jacobsson, Ragnar Hultborn, Håkan Andersson, Per Albertsson, Michael R. McDevitt, Jörgen Elgqvist and George Sgouros and has published in prestigious journals such as PLoS ONE, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Stig Palm

53 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MIRD Pamphlet No. 22 (Abridged): Radiobiology and Dosimetry of α-Particle Emitters for Targeted Radionuclide Therapy

2010 384 citations George Sgouros, John C. Roeske et al. Journal of Nuclear Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stig Palm Sweden	23	1.6k	755	431	295	134	53	1.9k
Tom Bäck Sweden	28	1.8k 1.1×	756 1.0×	450 1.0×	308 1.0×	158 1.2×	71	2.0k
Sture Lindegren Sweden	25	1.7k 1.0×	708 0.9×	413 1.0×	230 0.8×	154 1.1×	79	1.9k
Robert F. Hobbs United States	32	2.2k 1.3×	1.1k 1.5×	563 1.3×	773 2.6×	147 1.1×	116	2.7k
Cécilia Hindorf Sweden	21	1.3k 0.8×	475 0.6×	256 0.6×	360 1.2×	67 0.5×	57	1.6k
Andrea Wittig Germany	26	1.0k 0.6×	809 1.1×	331 0.8×	752 2.5×	237 1.8×	108	2.3k
Roy H. Larsen Norway	32	2.5k 1.5×	1.5k 2.0×	906 2.1×	356 1.2×	181 1.4×	81	2.9k
Jörgen Elgqvist Sweden	16	862 0.5×	418 0.6×	199 0.5×	125 0.4×	89 0.7×	27	1.0k
Daniel J. Macey United States	27	1.3k 0.8×	455 0.6×	295 0.7×	290 1.0×	143 1.1×	58	1.7k
Price Jackson Australia	22	1.7k 1.0×	1.6k 2.1×	625 1.5×	407 1.4×	189 1.4×	52	2.6k
Melchiore Giganti Italy	21	646 0.4×	300 0.4×	180 0.4×	135 0.5×	86 0.6×	100	1.2k

Countries citing papers authored by Stig Palm

Since Specialization

Citations

This map shows the geographic impact of Stig Palm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stig Palm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stig Palm more than expected).

Fields of papers citing papers by Stig Palm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stig Palm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stig Palm. The network helps show where Stig Palm may publish in the future.

Co-authorship network of co-authors of Stig Palm

This figure shows the co-authorship network connecting the top 25 collaborators of Stig Palm. A scholar is included among the top collaborators of Stig Palm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stig Palm. Stig Palm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Aneheim, Emma, Tom Bäck, Holger Jensen, Stig Palm, & Sture Lindegren. (2024). A proposed production method for astatinated (At-211) Trastuzumab for use in a Phase I clinical trial. PLoS ONE. 19(9). e0307543–e0307543. 2 indexed citations

Albertsson, Per, Tom Bäck, Karin Bergmark, et al.. (2023). Astatine-211 based radionuclide therapy: Current clinical trial landscape. Frontiers in Medicine. 9. 1076210–1076210. 49 indexed citations

Kato, Keiichi, et al.. (2023). O-242 Comparing the performance of an artificial intelligence model for predicting embryo implantation between clinics with patient cohorts of different maternal age distributions. Human Reproduction. 38(Supplement_1). 2 indexed citations

Hallqvist, Andreas, Lars Jacobsson, Per Karlsson, et al.. (2022). Estimating the Risk for Secondary Cancer After Targeted α-Therapy with²¹¹At Intraperitoneal Radioimmunotherapy. Journal of Nuclear Medicine. 64(1). 165–172. 5 indexed citations

Lindegren, Sture, Per Albertsson, Tom Bäck, et al.. (2020). Realizing Clinical Trials with Astatine-211: The Chemistry Infrastructure. Cancer Biotherapy and Radiopharmaceuticals. 35(6). 425–436. 69 indexed citations

Bäck, Tom, Karin Jennbacken, Sture Lindegren, et al.. (2020). Targeted alpha therapy with astatine-211-labeled anti-PSCA A11 minibody shows antitumor efficacy in prostate cancer xenografts and bone microtumors. EJNMMI Research. 10(1). 10–10. 26 indexed citations

Hallqvist, Andreas, Karin Bergmark, Tom Bäck, et al.. (2019). Intraperitoneal α-Emitting Radioimmunotherapy with²¹¹At in Relapsed Ovarian Cancer: Long-Term Follow-up with Individual Absorbed Dose Estimations. Journal of Nuclear Medicine. 60(8). 1073–1079. 60 indexed citations

Palm, Stig, Tom Bäck, Sture Lindegren, et al.. (2017). Model of Intraperitoneal Targeted α-Particle Therapy Shows That Posttherapy Cold-Antibody Boost Enhances Microtumor Radiation Dose and Treatable Tumor Sizes. Journal of Nuclear Medicine. 59(4). 646–651. 8 indexed citations

Palm, Stig, Lars Rönnbäck, & Boo Johansson. (2017). Long-term mental fatigue after traumatic brain injury and impact on employment status. Journal of Rehabilitation Medicine. 49(3). 228–233. 52 indexed citations

10.

Bäck, Tom, Emma Aneheim, Ragnar Hultborn, et al.. (2017). Therapeutic efficacy of α-radioimmunotherapy with different activity levels of the 213Bi-labeled monoclonal antibody MX35 in an ovarian cancer model. EJNMMI Research. 7(1). 38–38. 19 indexed citations

11.

Palm, Stig, Tom Bäck, Börje Haraldsson, et al.. (2016). Biokinetic Modeling and Dosimetry for Optimizing Intraperitoneal Radioimmunotherapy of Ovarian Cancer Microtumors. Journal of Nuclear Medicine. 57(4). 594–600. 19 indexed citations

12.

Bäck, Tom, Nicolas Chouin, Sture Lindegren, et al.. (2016). Cure of Human Ovarian Carcinoma Solid Xenografts by Fractionated α-Radioimmunotherapy with ²¹¹At-MX35-F(ab′)₂: Influence of Absorbed Tumor Dose and Effect on Long-Term Survival. Journal of Nuclear Medicine. 58(4). 598–604. 18 indexed citations

13.

Aneheim, Emma, Per Albertsson, Tom Bäck, et al.. (2015). Automated astatination of biomolecules – a stepping stone towards multicenter clinical trials. Scientific Reports. 5(1). 12025–12025. 32 indexed citations

14.

Andersson, Håkan, Peter Bernhardt, Tom Bäck, et al.. (2015). Absorbed Doses and Risk Estimates of 211At-MX35 F(ab')2 in Intraperitoneal Therapy of Ovarian Cancer Patients. International Journal of Radiation Oncology*Biology*Physics. 93(3). 569–576. 41 indexed citations

15.

Sgouros, George, John C. Roeske, Michael R. McDevitt, et al.. (2010). MIRD Pamphlet No. 22 (Abridged): Radiobiology and Dosimetry of α-Particle Emitters for Targeted Radionuclide Therapy. Journal of Nuclear Medicine. 51(2). 311–328. 384 indexed citations breakdown →

16.

Sofou, Stavroula, Richard M. Enmon, Stig Palm, et al.. (2010). Large anti-HER2/neuliposomes for potential targeted intraperitoneal therapy of micrometastatic cancer. Journal of Liposome Research. 20(4). 330–340. 12 indexed citations

17.

Zimmerman, Brian E. & Stig Palm. (2009). Results of an international comparison of 57Co. Applied Radiation and Isotopes. 68(7-8). 1217–1220. 7 indexed citations

18.

Elgqvist, Jörgen, Håkan Andersson, Peter Bernhardt, et al.. (2006). Administered activity and metastatic cure probability during radioimmunotherapy of ovarian cancer in nude mice with 211At-MX35 F(ab′)2. International Journal of Radiation Oncology*Biology*Physics. 66(4). 1228–1237. 28 indexed citations

19.

Ballangrud, Åse, Stig Palm, Richard M. Enmon, et al.. (2004). Alpha-Particle Emitting Atomic Generator (Actinium-225)-Labeled Trastuzumab (Herceptin) Targeting of Breast Cancer Spheroids. Clinical Cancer Research. 10(13). 4489–4497. 89 indexed citations

20.

Andersson, Håkan, Jörgen Elgqvist, György Horváth, et al.. (2003). Astatine-211-labeled Antibodies for Treatment of Disseminated Ovarian Cancer. Clinical Cancer Research. 9(10). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact